Active endovascular treatment and radical resection should be considered in patients with Trousseau syndrome and malignant tumors.
Why this matters
Trousseau syndrome generally produces neurological symptoms that are associated with latent malignant tumors. Its prognosis is poor, especially if the lower extremities, lung, brain, heart, kidneys, or spleen are affected.
Curative therapy for Trousseau syndrome involves tumor resection, but this may not be possible in patients with advanced cancer.